Laird Norton Trust Company, LLC Gamida Cell Ltd. Transaction History

Laird Norton Trust Company, LLC

  • $738 Million
  • Q1 2024

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 03, 2022
SELL
$1.73 - $4.29 $915,348 - $2.27 Million
-529,103 Closed
0 $0
Q2 2021

Aug 09, 2021
BUY
$5.85 - $8.33 $3.1 Million - $4.41 Million
529,103 New
529,103 $3.39 Million

Others Institutions Holding GMDA

# of Institutions
58
Shares Held
11.4M
Call Options Held
235K
Put Options Held
70.5K
View Full List

About Gamida Cell Ltd.

GMDA Quotes by TradingView
  • Ticker GMDA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 76,319,600
  • Market Cap $2.29M
  • Description
  • Gamida Cell Ltd., a clinical-stage biopharmaceutical company, develops cell therapies to cure blood cancers and serious hematologic diseases. The company's lead product candidate is omidubicel, a cell therapy that has completed Phase III clinical trial in patients with high-risk hematologic malignancies, as well as in Phase I/II clinical trials ...
More about GMDA
Track This Portfolio

Track Laird Norton Trust Company, LLC Portfolio

Follow Laird Norton Trust Company, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Laird Norton Trust Company, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Laird Norton Trust Company, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email